Advances in the treatment of multiple myeloma.

Advances in internal medicine

Volumn 43, Issue , 1998, Pages 279-320

  Barlogie, B ^a   Jagannath, S ^a   Tricot, G ^a   Desikan, K R ^a   Fassas, A ^a   Siegel, D ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

AGE; AGED; ALLOTRANSPLANTATION; AUTOTRANSPLANTATION; BIOLOGY; BONE MARROW TRANSPLANTATION; CANCER STAGING; CASE CONTROL STUDY; COMPARATIVE STUDY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; KIDNEY DISEASE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; MULTIPLE MYELOMA; PATHOLOGY; PATHOPHYSIOLOGY; PHASE 2 CLINICAL TRIAL; PROGNOSIS; REVIEW; SALVAGE THERAPY;

AGE FACTORS; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOLOGY; BONE MARROW TRANSPLANTATION; CASE-CONTROL STUDIES; CLINICAL TRIALS, PHASE II; COMBINED MODALITY THERAPY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; KIDNEY DISEASES; MIDDLE AGED; MULTIPLE MYELOMA; NEOPLASM STAGING; PROGNOSIS; SALVAGE THERAPY; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0031602052     PISSN: 00652822     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (108)